United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 25, 2026 · Filed Aug 26, 2026

On Aug 25, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$517.71 for US$4.92M under a trading plan, leaving 324,443 shares. Filed Aug 26, 2026 (Form 4).

Sold
9,500 shares
Price
US$517.71 average (US$516.12 to US$520.50)
Value
US$4.92M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 25, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 25, 2026Common StockSale2,029US$516.12331,914Indirect
Aug 25, 2026Common StockSale2,332US$516.95329,582Indirect
Aug 25, 2026Common StockSale2,004US$518.08327,578Indirect
Aug 25, 2026Common StockSale2,387US$518.80325,191Indirect
Aug 25, 2026Common StockSale668US$519.91324,523Indirect
Aug 25, 2026Common StockSale80US$520.50324,443Indirect

Source

View original at SEC

Related